A new variant of sphingomyelinase deficiency (Niemann‐Pick): visceromegaly, minimal neurological lesions and low in vivo degradation rate of sphingomyelin
- 5 November 1985
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 9 (4) , 357-366
- https://doi.org/10.1007/bf01800485
Abstract
Three males (aged 10 years, 3 years 9 months and 2 years 8 months) with profound sphingomyelinase deficiency are presented. The sphingomyelin storage in the liver biopsies attained 30-fold, 65-fold and 16-fold increases against controls, respectively. Levels of bis(monoacylglyceryl) phosphate were also increased. In two cases the bone marrow contained foam cells with liquid crystals of sphingomyelin. Besides the visceral involvement dominated by hepatosplenomegaly, all three cases showed discrete, so far stationary (8 years, 42 months and 28 months) neuropathic features and retinal lesions resembling the classical cherry-red spot. Electrophysiological examinations showed a variable reduction of peripheral nerve conduction velocity and prolongation of the latencies of somatosensory, visual and auditory evoked potentials. Ultrastructural examination of skin nerves showed a slight storage, mainly in Schwann cells. In some myelinated fibres there were pseudomyelinic ovoids. The cases therefore displayed features of both A and B types of sphingomyelinase deficiency and should be conventionally classified as intermediate. However, the very low levels ofin vivo sphingomyelin hydrolysis (not exceeding 6%, against 30±10% in type B and 77±5% in controls) were clearly within the range of type A values (5±2%). Accordingly, we suggest that the cases may be biochemically classified as variants of type A disease.Keywords
This publication has 26 references indexed in Scilit:
- Adrenal changes in Niemann-Pick disease: Differences between sphingomyelinase deficiency and type CActa Histochemica, 1985
- Biochemical studies in Niemann‐Pick disease. III: In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the diseaseClinical Genetics, 1985
- Niemann-Pick disease: Lipid storage in bone marrow macrophagesJournal of Molecular Histology, 1983
- Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with niemann-pick disease and other lysosomal storage diseasesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Niemann-Pick disease (variation in the sphingomyelinase deficient group)European Journal of Pediatrics, 1983
- In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and CBiochemical and Biophysical Research Communications, 1982
- Metabolism of sphingomyelin by intact cultured fibroblasts: Differentiation of Niemann-Pick disease types A and BBiochemical and Biophysical Research Communications, 1982
- Peripheral neuropathy in classic Niemann‐Pick diseaseNeurology, 1975
- THE CEREBRAL DEFECT IN TAY‐SACHS DISEASE AND NIEMANN‐PICK DISEASE*Journal of Neurochemistry, 1961
- NIEMANN-PICK DISEASEMedicine, 1958